This genetic mapping helps PlexusDx identify your optimal medication type and initial dosing strategy, increasing the likelihood of success with semaglutide or other GLP-1 therapies
Most blog content about this topic falls into two camps
These individuals often show blunted GLP-1 responses after meals, suggesting that improving baseline metabolic health can restore more robust GLP-1 signaling over time (Huber et al., 2024)
Understanding why tirzepatide may not be working requires examining multiple factors: treatment duration, dosing adequacy, individual metabolic variability, medication adherence, lifestyle behaviors, and potential drug interactions
Another study revealed that systemic inflammation can directly alter glucose metabolism within the insula and anterior cingulate cortexkey nodes of the interoceptive network (147)